ETAGEN Pharma was founded in 2014 by leaders in Therapeutic Editing™ Dr. Tod Woolf and Dr. Richard Hogrefe. ETAGEN's goal is to correct disease by selectively editing out mutated sequences and to prevent disease by editing in protective genomic variants in tissues. ETAGEN is headquartered in Massachusetts, with chemical synthesis performed by TriLink Biotechnologies in San Diego, California.
View Top Employees from ETAGEN Pharma| Website | http://www.etagenpharma.com |
| Revenue | $4 million |
| Employees | 1 (1 on RocketReach) |
| Founded | 2014 |
| Address | 111 E 48th St, New York City, New York 10017, US |
| Industry | Business Services General, Biotechnology, Business Services, Science and Engineering, Chemical |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies, NAICS Code 54 Companies |
Looking for a particular ETAGEN Pharma employee's phone or email?
ETAGEN Pharma Questions
The ETAGEN Pharma annual revenue was $4 million in 2024.
Amy Tata is the Senior Director of Financial Operations of ETAGEN Pharma.
1 people are employed at ETAGEN Pharma.
ETAGEN Pharma is based in New York City, New York.
The NAICS codes for ETAGEN Pharma are [54171, 541, 541714, 5417, 54].
The SIC codes for ETAGEN Pharma are [87, 873].
Top ETAGEN Pharma Employees
